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Objective. The purpose of this glossary is to offer an updated guide to the correct terminology for con-
trast-enhanced sonography. Methods. This report was prepared by a panel of radiologists from the
Sonography Section of the Italian Association of Medical Radiology. A leading author prepared a list of
terms based on a comprehensive literature survey. The draft was analyzed by 3 experts on the topic of
contrast-enhanced sonography. These reviewers reached a consensus and prepared the final version.
Results. A list of 137 terms is included. These terms are briefly defined. Their proper application is dis-
cussed, with special reference to potential misleading uses. Conclusions. Contrast-enhanced sonog-
raphy is a relatively new diagnostic tool, now entering clinical practice in several countries. Use of
appropriate, universal terminology is mandatory in the scientific setting to allow comparison between
different published experiences. Additionally, use of clear, standardized terminology is necessary in
the clinical setting to facilitate report understanding by the referring physician. Standardized,
nonequivocal nomenclature may also help future diffusion of sonographic contrast media in countries
where their application is still not approved. Key words: contrast media; contrast-enhanced sonogra-
phy; ultrasound terminology.
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Abbreviations
CT, computed tomography; HCC, hepatocellular carci-
noma; MI, mechanical index; MRI, magnetic resonance
imaging
onographic contrast media became commercially
available in the mid-1990s. In the United States,
heart chamber opacification and delineation of the
endocardial border are the only applications
approved by the US Food and Drug Administration to
date. Conversely, in many European and Asian countries,
sonographic contrast media have greatly entered clinical
practice. The first noncardiac application was to boost
the Doppler signal from medium to small vessels.
Subsequently, specific imaging techniques were devel-
oped to obtain optimal contrast-enhanced gray scale
scans, intermittently or in real time. This spread of tech-
nologies has created some nomenclature confusion
among different modalities.1 Additionally, although
many imaging findings are similar between contrast-
enhanced sonography and contrast-enhanced comput-
ed tomography (CT) or magnetic resonance imaging
(MRI), these techniques are not properly superimpos-
able. Sonographic contrast media have different behavior
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within the human body compared with iodinat-
ed and paramagnetic agents. The signal from
contrast medium microbubbles varies with the
type of insonation, and each contrast medium
has its own peculiarities. All published articles
should clearly state in the abstract and full text
the contrast medium and the contrast-enhanced
sonographic techniques used.
As in any field of medicine, use of appropriate,
agreed terms is mandatory, both in the scientif-
ic setting and in clinical practice.1 This glossary
is the result of a consensus panel of the
Sonography Section of the Italian Association of
Medical Radiology, including its president and 
3 other experts. The purpose is to clarify some
potentially confusing aspects of contrast-
enhanced sonographic terminology. Terms
included mostly refer to contrast-enhanced
sonographic findings and to contrast-enhanced
sonographic techniques (also including the ter-
minology used by the various manufacturers).
The various terms are only briefly described
because a detailed comparison of the different
techniques is outside the scope of this report.
Consistency of terminology may improve com-
parison of published results and may help radiol-
ogists in daily reporting. In some instances, the
descriptions listed below may reflect the authors’
own opinions. Hence, some readers may disagree.
We invite all readers to send us their suggestions
and comments. 
Glossary
1.5 harmonic contrast-enhanced sonography—
A contrast-enhanced modality in which images
are obtained in a frequency band intermediate
between the fundamental mode and second har-
monic mode and whose center frequency is
higher than the fundamental by a factor of 3/2.2
acoustic power (or energy)—The amount of
energy contained in the acoustic waves transmit-
ted by a transducer per second. See mechanical
index.
acoustic pressure—The stress, either tension or
compression, exerted on the material (eg, tissue,
blood, or bone) through which the acoustic wave
travels. See mechanical index.
advanced dynamic flow—A high-resolution,
wideband pseudo-Doppler technique capable of
showing macrovascularization.3 Applicable to
contrast imaging (contrast-enhanced advanced
dynamic flow) as a high-mechanical index (MI)
technique in which bright color signals are
superimposed on a B-mode image. 
agent detection imaging (cadence)—A nonlin-
ear, multipulse intermittent contrast-enhanced
sonographic technique that detects signals from
microbubble disruption within a color Doppler
box.4,5 Two identical high-amplitude pulses are
transmitted, with temporary storage of the
received related echo sequences and subsequent
subtraction of the second from the first. Both
fundamental and contrast-enhanced harmonic
echoes are used, and echoes are coded according
to the intensity scale of the color Doppler signal.
angiosonography (also sonographic angiogra-
phy or angiographic sonography)6,7—Real-time
gray scale assessment of organ and lesion
enhancement (perfusion). May be confused with
an intravascular, catheter-assisted technique;
hence, this term should be avoided. 
annular (arterial) enhancement—See rim (arte-
rial) enhancement.
arterial phase of enhancement—The phase of
contrast medium circulation when contrast-
enhanced blood reaches an organ through its
arterial supply. It starts a few seconds after the
enhancement of large arteries. In this phase,
parenchymal and lesional enhancement results
exclusively from arterial flow (although in the
liver, there is a rapid overlap with the portal-
venous induced enhancement). In the liver, this
vascular phase starts 10 to 20 seconds after con-
trast medium injection in a peripheral vein and
ends as soon as 30 to 40 seconds after injection,
also depending on the agent used.1,8–11 The syn-
onymous term early phase12 should be avoided
because it may be erroneously intended as the
whole vascular phase (in opposition to the late or
postvascular phase).
atypical hemangioma—A hemangioma without
the typical enhancement pattern (ie, peripheral
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globular enhancement with progressive fill-
in).6,13–15 An atypical hemangioma may show a
very fast and homogeneous enhancement or a
very slow enhancement with incomplete fill-in. 
avascular lesion—A lesion appearing anechoic,
with lack of contrast enhancement (markedly
negative lesion-to-parenchyma contrast gradi-
ent). There is no subjective or measured differ-
ence in lesion echogenicity before and after
contrast medium injection.
backscattering—Energy (ultrasound) reflected
or radiated backward by a scatterer, in a direc-
tion opposite to the incident beam’s direction of
travel.16,17
bandwidth—The range of frequencies contained
in an ultrasound beam.16,17 Frequencies within
which a transducer can operate. Frequencies
may vary from a broad band to a narrow band.
Contrast-enhanced sonography typically uses a
limited range of frequencies, but wideband
modalities have also been developed.18
basket pattern—Color Doppler and contrast-
enhanced sonographic pattern of macrovascu-
larization consisting of a vascular ring that
circumscribes the lesion starting from a pole and
then gives discrete, irregular branches intrale-
sionally. A common feature of hepatocellular
carcinoma (HCC).13,19
blood pool contrast media—Those contrast
media that remain within the vascular bed and
do not spread in the interstitium. Blood pool
agents act as flow tracers.
blooming artifact (color)—A contrast medium-
induced color Doppler artifact resulting from
color signal oversaturation at the moment of
contrast-enhanced blood arrival in the scanned
area.20–22 Specifically, gray scale pixels are seen
changing to a color display in regions where flow
is not present. To avoid this phenomenon, it is
necessary to decrease color gain, decrease out-
put power, or inject the contrast medium more
slowly. Any of these maneuvers, however, may
present an obstacle to effective imaging of
lesions.
B-mode (or brightness modulation) contrast-
enhanced sonography—Use of the term B-mode
may create confusion with B-flow sonography, a
recently developed non–Doppler-based modality
capable of showing large vessel flow with a high
frame rate and without contrast medium injec-
tion. Use contrast-enhanced sonography.
bubble noise artifact (spectral)—A spectral
Doppler artifact due to the presence of contrast
medium microbubbles within the sampled vol-
ume.20–22 Sharp, needle-shaped signals of high
amplitude appear on the Doppler spectrum, and
a crackling noise is heard in the audio. Spectral
Doppler analysis should be performed before
contrast medium injection. Otherwise, it may
be necessary to decrease Doppler gain and to
increase Doppler signal filtering. Further
research is needed to determine the effects of
sonographic contrast media on the spectral
waveform.
carbon dioxide-enhanced sonography—
Transabdominal imaging of the liver during tran-
scatheter injection of carbon dioxide in the
hepatic arterial system. Vascularized lesions
become hyperechoic for up to 10 to 15 minutes.23
C-cube (C3) mode—A nonlinear, harmonic
intermittent contrast-enhanced sonographic
technique using comparative digital decorrela-
tion and a digital adaptive bandpass filtering
process.24 Two identical pulses are transmitted
for each line; returning signals are compared;
and the nonlinear response from microbubbles
is selected.25
central (arterial) spider sign4—See centrifugal
(arterial) blood supply.
centrifugal (arterial) blood supply—Color
Doppler and contrast-enhanced sonographic
pattern of intralesional macrovascularization
consisting of a vessel that branches from the cen-
ter toward the periphery of a lesion.26 Discrete
arteries show progressive enhancement from the
center to the periphery, with an overall stellate
distribution. It is a common pattern of focal
nodular hyperplasia. Overall appearance is also
referred to as spoke wheel like, stellate, star like,
J Ultrasound Med 2007; 26:717–730 719
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or spider like,4,10,12,13 but these figurative terms
should be avoided. Do not confuse with centrifu-
gal enhancement.
centrifugal enhancement—Progressive enhance-
ment of a lesion from the center to the periphery.
An uncommon feature of liver hemangioma and
peliosis hepatis. Centrifugal blood supply has also
been described27 as centrifugal radiating enhance-
ment, which is confusing.
centripetal enhancement—Progressive enhance-
ment of a lesion from the periphery to the center,
predominantly during the arterial or the portal
phase. A common pattern of liver hemangioma, in
which globular enhancement is followed by pro-
gressive (rapid or slow, complete or incomplete)
filling in. 
coded harmonic angio—A pulse inversion tech-
nology in which pulse inversion harmonic imag-
ing is combined with a so-called coded excitation
technique, transmitting coded pulse sequences
and decoding them on receipt. The decoder sup-
presses the immobile (nonvascular) signals for
each scan line.26,28
coherent contrast imaging—A nonlinear, har-
monic, high-frame rate technique in which the
phase of each transmitted pulse is alternated
during the scanning process. Echoes, corre-
sponding to the scan line between 2 pulses, are
calculated and summed. Nonlinear echoes are
finally selected and form the basis of the
enhanced image. This is a pulse inversion tech-
nique based on alternate line phasing.10,29
continuous mode—Real-time (rapid-frame rate,
sequence display) acquisition techniques for
imaging microbubbles, usually with a low-inten-
sity beam. 
contrast arrival (imaging at)—Assessment of
echogenicity during the first passage of contrast-
enhanced blood through an organ, at the
moment of a notable rise in signal. The optimal
phase for functional studies.12,30
contrast arrival time—The time intervening
between the beginning of contrast medium
bolus injection and notable arrival of enhanced
blood within a given organ vessel.30
contrast burst imaging—A technique derived
from power Doppler sonography in which pulses
are broadband and with high power output lev-
els, which may destroy or modify microbubble
shape and size.31 These changes are reflected in
the amplitude and spectral energy distribution of
the echoes, so that short sequences of 6 to 10
pulses per line can reveal microbubble presence.
The changes are then detected as broadband
noise in the Doppler spectrum. Alternatively,
changes are shown as characteristic features of
microbubbles using dedicated algorithms (see
time variance imaging).32
contrast-coded sonography—Synonymous with
contrast-enhanced sonography. Radiologists pre-
fer avoiding contrast-coded sonography because
of lower similarity with contrast-enhanced CT
and MRI.
contrast-enhanced Doppler technique—Color
Doppler or especially power Doppler acquisition
being performed after contrast medium injec-
tion. The Doppler signal is amplified (increased
in intensity) by the circulating contrast agent.
contrast-enhanced sonographic angiography—
Also described as B-mode sonographic angiogra-
phy. These terms are occasionally used to
indicate imaging of large vessels with contrast-
enhanced sonography. The term angiography
may raise the idea of an intravascular, catheter-
assisted technique and should be avoided.
contrast-enhanced sonography—Every sono-
graphic technique performed with injection of a
contrast medium. Nevertheless, this term should
be used to indicate gray scale modalities, where-
as use of Doppler techniques should be specifi-
cally indicated (ie, the term contrast-enhanced
sonography without any other explanation
should be considered as referring to a gray scale
modality). 
contrast enhancement—The increase in echo
intensity in an organ or lesion due to a contrast
medium. Contrast enhancement is a commonly
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used term in diagnostic imaging, although post-
contrast intensity would be a more appropriate
term in contrast-enhanced sonographic nomen-
clature.1,19 Similarly, hypoechoic, isoechoic, and
hyperechoic might be useful to describe static find-
ings underlying unenhanced sonographic imag-
ing but are ambiguous for explaining dynamic
phenomena underlying contrast-enhanced sono-
graphic imaging. A lesion may show an enhance-
ment weaker than, equal to, or stronger than
surrounding parenchyma. Hence, terms to be
used for contrast-enhanced sonography should
properly be hypoenhanced, isoenhanced, and
hyperenhanced.1,19 Nevertheless, hypoechoic,
isoechoic, and hyperechoic have entered clinical
practice. Enhancement is also termed the
increase in echo amplitude from tissue lying dis-
tal to a weak reflector such as a cyst. Avoid con-
fusion between these two uses of the word
enhancement.1
contrast extravasation—The detection of
microbubble signals from extravasated blood
after intravenous contrast medium injection.33
From this point of view, it is a sign of ongoing
macroscopic bleeding because usual sono-
graphic contrast media are intravascular.
Nevertheless, extravasation is also the term to
be used for micromolecular contrast agents.
This is a class of experimental sonographic con-
trast media in the nanomolecular range, in
which extravasation occurs in early stages of
cancer (before neovascularization) because of
increased capillary permeability.
contrast medium—A sonographic contrast
medium is an agent capable of changing the
acoustic impedance through tissues.11,16,17,34
Although these agents work rather differently
from x-ray and MRI agents, the term contrast
medium is universal in diagnostic imaging and
should be preferred to echo amplifier and echo
enhancer. “First-generation” contrast media
include those microbubbles containing air and
capable of emitting a signal during disruption at
high-MI beam exposure. “Second-generation”
media include those microbubbles filled with
gases other than air and capable of emitting a
signal also during oscillation at low-MI beam
exposure. Each contrast medium has its own
kinetics when injected and shows its own behav-
ior when insonated at different acoustic powers
and frequencies.1,34
contrast pulse sequencing (cadence)—A real-
time, multipulse technique in which 3 pulses
that differ in amplitude and phase are sent down
each scan line. Opportune scaling and subse-
quent addition of each echo allow detection of
contrast medium-related, nonlinear fundamen-
tal and harmonic signals while the linear tissue
signal is rejected. Contrast pulse sequencing has
the immediate advantage of enabling observa-
tion of the fundamental signals coming from tis-
sue at the same time as signals coming from a
nonlinear fundamental response of the contrast
medium. Contrast pulse sequencing may result
in an increase in signal intensity greater than that
of second harmonics of the contrast medium
alone.1,10,32
contrast-specific sonography10,25—Synonymous
with contrast-enhanced sonography. To be
avoided. 
contrast transit time—The time interval between
microbubble arrival in the artery feeding an
organ and their arrival within the related venous
drainage. Useful for functional studies because
microbubbles do not spread within the intersti-
tium.
contrast-tuned imaging—A harmonic, contrast-
enhanced technique producing images on the
basis of both maintenance of microbubbles at
low acoustic pressure and subtraction imaging.
The sonographic system is selectively synchro-
nized to the harmonic signal from microbubbles
when stimulated by a very narrowband, single
pulse at the contrast medium resonance fre-
quency.10,13
conventional sonography—Frequently used to
indicate a sonographic acquisition that is not
based on contrast media injection. The term
unenhanced sonography should be used instead.
destruction (or destructive) mode11—Trans-
mission of 1 or more high-intensity acoustic
pulses to temporarily reduce or eliminate con-
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trast enhancement, used in combination with
low-power continuous mode or intermittent
mode imaging techniques (see above and below).
Not a standalone imaging modality. This term
should be avoided because it may raise an idea of
radiation invasiveness, recalling, for example,
high-intensity focused ultrasound. Use intermit-
tent mode.
destruction-replenishment (or destruction-
reperfusion) technique—A method of perfusion
quantification based on microbubble disruption
within a selected area of interest and subsequent
assessment of its refilling by new, incoming
microbubbles. 
delayed phase of enhancement—See parenchy-
mal phase of enhancement and sinusoidal phase
of enhancement.
diffuse enhancement—Enhancement distribut-
ed throughout a lesion. Can be homogeneous or
heterogeneous and in the liver may occur in the
arterial, portal, or sinusoidal phase.
dynamic (contrast-enhanced) sonography—
Occasionally used to indicate contrast-enhanced
sonography with intermittent or especially with
continuous acquisition of the images.35 Strictly,
only real-time images can be termed dynamic.
Term to be avoided.
early phase of enhancement1,2—See arterial
phase of enhancement.
echo amplifier (or enhancer)—An agent increas-
ing gray scale or color-coded echo levels. This
term arose during the early days of contrast-
enhanced sonography, when these agents were
used to amplify hard-to-detect Doppler signals.
The term contrast medium should be used
instead.
echo contrast agent—Synonymous with sono-
graphic contrast medium. Avoid.
filling in—See centripetal enhancement. Not to be
used12 to describe the enhancement of a central
branching vessel within a focal nodular hyperpla-
sia nodule (see centrifugal blood supply).
filling out—See centrifugal enhancement.
flash—A sudden rise in acoustic power (MI) that is
triggered by the operator to better assess a given
area or to destroy the microbubbles filling the
insonated parenchymal region and obtain func-
tional data from the refilling kinetics of microbub-
bles (destruction-replenishment technique).
flash echo imaging—A nonlinear, intermittent
harmonic contrast-enhanced sonographic tech-
nique based on generating 2 high-power pulses
separated by a variable interval. The longer the
time interval between the 2 high-transmit power
pulses, the greater the microbubble accumula-
tion and the higher the signal produced by the
second insonation. The subtraction image is
derived from combining the second image with
the first.
focus—The concentration of a pulse into a
smaller area than would be the case other-
wise.16,17 In contrast-enhanced sonography, the
beam focus is placed by the operator at the level
of the region of interest or at its deeper aspect.
The MI varies with focus depth choice.
frame rate—The number of frames (images) dis-
played per second.17
fundamental mode—“Conventional” (gray
scale) sonographic and Doppler techniques
based on the transmission frequency of a sonog-
raphy system.16,17 The echo at the same frequen-
cy as that of the transmitted frequency is chosen
to create the image (linear response). Opposite to
nonlinear, harmonic mode. 
globular enhancement (peripheral)—A discon-
tinuous ring of contrast-enhanced peripheral
globules (puddles or nodules) predominantly in
the arterial or portal phase.6,9 These globules
usually enlarge over time, with centripetal
enhancement of the lesion. This is a common
feature of liver hemangioma. Terms such as
nodular and peripheral nodular are also
used,5,10,15,19,36,37 but they can be misleading, rais-
ing in the reader the idea of smaller nodules
within the nodule. Terms such as cotton-like and
wool-like enhancement27 should be avoided.
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gray scale contrast-enhanced sonography—
Brightness-mode (B-mode) display of echo
intensity enhanced by the presence of a contrast
medium. Initially, this term was used to distin-
guish contrast-enhanced sonography from for-
mer contrast medium-amplified Doppler
techniques. There is no current need to specify
either gray scale or B-mode when simply refer-
ring to contrast-enhanced sonography. Instead,
use of Doppler techniques should be clearly
indicated.
harmonic imaging—Any technique in which
nonlinear echoes, that is, echoes at frequencies
greater than the transmission frequency, are pref-
erentially selected to create the image.12,16,17,25
Usually, it is the signal at twice the transmission
frequency that is considered. Hence, this modal-
ity is also termed second harmonic imaging.
Images can be based on tissue (native) harmon-
ics generated from beam propagation through
matter to obtain high-quality, detailed images
(tissue harmonic imaging).25 Images can also be
based on contrast medium-induced harmonics
(contrast-enhanced harmonic imaging).24
high-flow lesion—A lesion showing a very rapid
enhancement in the arterial phase.
honeycomblike enhancement—Inhomogeneous
enhancement with gross enhancing septa and
with small or large unenhanced areas that are
more than half the size of the lesion area (on
2-dimensional images).12,27,38 Found in liver
abscesses. A particular type of inhomogeneous
enhancement.
hypervascular (or hyperenhanced) lesion—
A lesion with relatively stronger echogenicity
(enhancement) than the surrounding normal
parenchyma (positive lesion-to-parenchyma
contrast gradient). Lesion echogenicity (vascu-
larity) may vary over contrast medium circula-
tion phases, aside from lesion vessel density at
pathologic evaluation.8 Describing a lesion as
“with intense signal”1 or as “with increased
intensity”19 when related to contrast-enhanced
sonography would be better than naming it
“hyperechoic.” 
hypovascular (or hypoenhanced) lesion—A
lesion with relatively weaker echogenicity
(enhancement) than the surrounding normal
parenchyma (relatively negative lesion-to-
parenchyma contrast gradient). Lesion
echogenicity (vascularity) may vary over con-
trast medium circulation phases, aside from
lesion vessel density at pathologic evaluation.8
Describing a lesion as “with low signal” or as
“with decreased intensity”19 when related to
contrast-enhanced sonography would be better
than naming it “hypoechoic.”
inhomogeneous enhancement—Coexistence of
enhanced and unenhanced areas without par-
ticular positions or morphologic characteristics
of these areas. Patterns such as mosaic or honey-
comblike enhancement are included among
inhomogeneous enhancement patterns.
intermittent mode—Very low-frame rate acqui-
sition, generally used during and immediately
after the destruction mode.14,16,17 The high-
power pulses of the destruction mode may be
emitted automatically under software control or
manually by the operator. Some protocols
include continuous acquisition during the arte-
rial phase and intermittent imaging thereafter.26
interpulse phase inversion29—See pulse (or
phase) inversion mode imaging.
interval delay imaging—When microbubbles
are disrupted by a high-pressure beam (see inter-
mittent mode) and intense enhancement is
detected, it is necessary to wait a minimum
interval to have replenishment of the insonated
area by new incoming microbubbles. Hence, the
intermittent mode is also known as an interval
delay scanning technique, but the former term
should be preferred.11,25,37
isovascular (or isoenhanced) lesion—A lesion
with the same echogenicity (enhancement) of
surrounding normal parenchyma and conse-
quently not identifiable from its own echogenic-
ity. Lesion echogenicity (vascularity) may vary
over contrast medium circulation phases, aside
from lesion vessel density at pathologic evalua-
tion.8 Describing a lesion as “with a similar signal
J Ultrasound Med 2007; 26:717–730 723
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in comparison with surrounding parenchyma”1
or as “isointense”19 when related to contrast-
enhanced sonography would be better than
naming it “isoechoic.”
jail bar artifact—A lack of color along some
image lines due to power Doppler signal satura-
tion after contrast medium injection.
late phase of enhancement9–11,19,27,36,39,40—See
parenchymal phase of enhancement and sinu-
soidal phase of enhancement.
liver-specific (late) phase of enhancement9,39,41—
See parenchymal phase of enhancement.
loss of correlation mode—See stimulated acous-
tic emission (acoustically).
low-flow lesion—A lesion showing very slow
enhancement over time.
macrocirculation (tumor)—Major intranodular
vessels seen as discrete, hyperechoic (hyperen-
hanced) vessels on contrast-enhanced scans.
marginal enhancement—Similar to rim en-
hancement but with a rim particularly irregular
and thick. Feature of hypovascular metastasis.
mechanical index—The peak rarefactional pres-
sure (in megapascals) divided by the square root
of the acoustic center frequency (in megahertz)
at a specified location in a uniform medium hav-
ing specific acoustic properties.1,4,16,17 The MI is a
safety parameter indicating the relative potential
risk of inducing an adverse effect in a patient by a
nonthermal mechanism. The MI decreases with
increasing focal depth, but it is only indirectly
related to the acoustic output power; thus, the MI
is not necessarily comparable between different
imaging machines. High-MI techniques (by defi-
nition, MI >1.0) can be performed with any con-
trast medium, but these generally perform well
only with intermittent image acquisition
(although some researchers4 have tried to com-
bine high-MI and continuous-mode imaging).
Low-MI techniques (by definition, MI <0.2) are
generally performed only with second-genera-
tion contrast media and allow prolonged real-
time image acquisition.11 Low- and high-acous-
tic pressure sonography would be more descrip-
tive nomenclature, but low- and high-MI
sonography has entered practice.
microbubble—Modern sonographic contrast
media usually consist of encapsulated gas bub-
bles with a mean diameter small enough (<10
µm) to pass through the capillary bed.11,34
Currently, there is no need to specify microbub-
ble contrast medium. 
microcirculation (tumor)—Tumor microvessels
developing as a consequence of neoangiogene-
sis. These vessels have a diameter of 2 to 5 µm,
which is below the resolution threshold of all in
vivo imaging modalities, contrast-enhanced
sonography included. Contrast-enhanced gray
scale sonography can detect signals from small
vessels, below the resolution of unenhanced
sonography and Doppler techniques. Contrast-
enhanced gray scale sonography allows demon-
stration of tumor enhancement, but it should be
always remembered that this only indirectly
reflects the tumor microcirculation.
microflow (microvascular) imaging—A tech-
nique based on summation of multiple consecu-
tive frames and representing a multi-intensity
projection algorithm of data. Improves depiction
of small capillary vessels with a low concentra-
tion of contrast medium.
mosaiclike enhancement—A term derived from
CT terminology to indicate patchy enhance-
ment, with only some enhanced area within a
lesion. Small unenhanced irregular portions,
which are less than half the lesion area, are visi-
ble. An HCC pattern.27,35 To be included within
the concept of inhomogeneous enhancement.
nodule-in-nodule appearance—Postcontrast
recognition of a nodule of different (usually
increased) echogenicity within a larger one.
Identified in early HCC.42
nondestructive mode—See continuous mode.
nonlinear mode—Those techniques mainly
detecting and forming images using the nonlin-
724 J Ultrasound Med 2007; 26:717–730
Terminology for Contrast-Enhanced Sonography
26.6.jum.703-.q  5/1/07  12:50 PM  Page 724
ear components of the echo.16,17 When stimulat-
ed by an acoustic beam, microbubbles oscillate
and emit signals at integer multiples of the fre-
quency of the stimulating pulse. Opposite to the
fundamental mode, in which a linear portion of
the response is used to form the image.
opacification—A term derived from x-ray ter-
minology. Increased echogenicity should be
termed enhancement and not opacification.
parametric imaging—Depiction of different
quantitative levels of a parameter in a color scale
according to their value. In contrast-enhanced
sonography, parametric imaging is used to
depict the different values of flow or perfusion
magnitude in the different parenchymal regions.
parenchymal phase of enhancement—Some
sonographic contrast media show first an
intravascular phase and then a more or less pro-
nounced phase of extravascular retention within
liver and spleen parenchyma. To image the liver
during this phase, scans are taken from 2 to 5
minutes after contrast medium injection up to 6
to 10 minutes, when the enhancing effect van-
ishes (depending on the type of contrast medi-
um used).9,28,35,37,39–41 The parenchymal phase is
also described as late, delayed, liver specific, or
postvascular, but parenchymal phase of (con-
trast) enhancement is the most appropriate
description. To avoid confusion, parenchymal
postvascular should not be used to describe the
venous-sinusoidal vascular phase of enhance-
ment. Terms such as late and delayed should be
eventually reserved for this vascular phase9 and
not to indicate postvascular enhancement.
peak intensity—Maximum increase in signal
produced by an intravenously injected contrast
medium.
perfusion—Total blood flow, including capillary
flow, in an organ (blood flow/tissue unit).
Perfusion of a tumor includes its microcircula-
tion, but it is not a synonymous term.
perfusion defect—An area of poor or absent
enhancement within the parenchyma. Infarction,
ischemia, or injury may appear as perfusion
defects within the normally enhanced sur-
rounding parenchyma. This term should not
be used to describe a focal lesion with lack of
enhancement.40
perfusion imaging—Imaging of flow at the cap-
illary level. Usually used as synonymous with
continuous mode, allowing real-time demonstra-
tion of parenchymal and lesional perfusion.
phase inversion imaging26,39—See pulse (or
phase) inversion mode imaging.
phases of contrast enhancement—In dynamic
CT and MRI, the concept of phase is limited to
the peak of enhancement in a given phase of
contrast-enhanced blood distribution. In con-
trast-enhanced sonography, instead, the term
phase refers to the entire duration of a given
phase.13,43 Particularly for the liver, which has a
double blood supply system, there is partial
overlap between the final part of the arterial
phase and the initial part of the portal phase, the
latter starting when the enhancement of portal
branches starts.35 For the liver, phases for con-
trast-enhanced sonography should be termed
arterial (vascular, ranging approximately from 15
to 40 seconds after peripheral contrast medium
injection), portal-sinusoidal (vascular, ranging
approximately from 40 to 300 seconds after
contrast medium injection), and eventually
parenchymal (postvascular, for those contrast
media showing late intraparenchymal uptake,
lasting up to 10 minutes after contrast medium
injection). All other terms are confusing. 
pooling (contrast)—A delimited (pseudo-
aneurysm) or an undelimited (extravasation)
collection of contrast medium.33 The term pooling
is also used26,28 to describe areas of enhancement,
such as the enhanced globes at hemangioma
periphery. This latter use is confusing and should
be replaced by globular enhancement.
portal (or portal venous) phase of enhance-
ment—The phase of contrast medium circula-
tion when contrast-enhanced blood reaches the
liver through the venous portal system (from 40
to 50 seconds after contrast medium injection to
100 to 120 seconds after injection).8–10 Because
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the liver has a double feeding system, arterial and
portal, the portal phase of enhancement is not
exactly the same concept as the venous phase in
other organs. This is the phase when liver
parenchyma (properly, small intrahepatic portal
vessels) reaches its peak of enhancement.
postvascular phase of enhancement—Some
sonographic contrast media show first an
intravascular phase and then a more or less pro-
nounced phase of intraparenchymal accumula-
tion. See parenchymal phase of enhancement.
power modulation imaging—Nonlinear tech-
niques in which 2 separate pulses are transmitted
down each scanning line, the second being at half
the acoustic pressure of the first. The second
returned signal is doubled and subtracted from the
first. The symmetric echoes from linear structures
such as tissues cancel each other, whereas those
from contrast-induced, harmonic components
(nonlinear scattering) produce the image line.
power pulse inversion imaging29—A multiply
transmitted pulse, color-coded pulse inversion
technique.
puddle enhancement—A term occasionally
used35 to describe areas of enhancement, such as
the enhanced globes at hemangioma periphery.
To be replaced by globular enhancement.
pulse inversion Doppler29—See power pulse
inversion imaging.
pulse (or phase) inversion mode imaging—
Nonlinear techniques in which 2 separate pulses
are transmitted down each scanning line, the sec-
ond being an inverted copy of the first (ie, 2 pulses
phase shifted by 180° for 1 image frame). On sum-
mation of the 2 returned signals, the symmetric
echoes from linear structures such as tissues cancel
each other, whereas those from contrast-induced,
harmonic components (nonlinear scattering) are
summed to produce the image line. Tissue pulse
inversion imaging and contrast-enhanced coded
pulse inversion harmonic imaging are both possi-
ble.10,12,25,26,29,37,42,44 Contrast-enhanced pulse inver-
sion may be used either as a continuous mode or
an intermittent mode.
pulse subtraction imaging—A nonlinear, wide-
band technique based on the phase modulation
principle to display a signal from microbubbles
as a B-mode, high-resolution image. Both inter-
mittent acquisition and continuous acquisition
are possible.
pure harmonic detection (extended)—A har-
monic technique in which a distortion-free, pure
sinusoidal fundamental pulse is transmitted, and
second harmonic echoes are selectively regis-
tered.10
real-time contrast-enhanced sonography—See
continuous mode.
recirculation—The effect of continuous circu-
lation of contrast-enhanced blood through
the pulmonary and peripheral circulation.
Microbubbles circulate through the lungs several
times before vanishing, and this allows sono-
graphic scanning for several minutes. Oppositely,
this phenomenon may impede functional stud-
ies because the recirculated microbubbles inter-
fere with building of a pure time-intensity curve. 
reflux—Contrast medium backflow within a hol-
low viscus through an ostium, for example,
spread of contrast medium from the bladder to
the ureter (ureterovesical reflux) or from the
stomach to the esophagus (gastroesophageal
reflux).
regurgitation—Contrast medium backflow
through a vascular ostium or segment, for exam-
ple, retrograde flow of contrast-enhanced blood
from the right atrium to hepatic veins. 
rim (arterial) enhancement—Also described as
ring enhancement or annular enhancement. A
continuous (thin or thick) annulus of peripheral
contrast enhancement in a lesion. This is a typi-
cal pattern seen in liver metastasis.4,9,10,19
ring (arterial) enhancement35,40—See rim (arte-
rial) enhancement.
second harmonic imaging—See harmonic
imaging. 
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signal amplifier (or enhancer)—An agent
increasing color-coded or spectral Doppler
color-coded signal levels. Refers to the beginning
of contrast-enhanced sonography practice,
when these agents were used to amplify a scarce
Doppler signal. The term contrast medium is
preferred.
single-level (or single-slice) technique—
Contrast-enhanced sonographic acquisition
modality done without any movement of the
transducer over the patient’s body surface.
Used for lesion characterization and functional
studies.45
sinusoidal phase of enhancement—The phase
of contrast medium circulation when contrast-
enhanced blood leaves the liver through its
venous drainage (from 90–120 seconds after
contrast medium injection to about 300 seconds
after contrast injection, depending on the con-
trast medium used).1,8,9,11 Liver enhancement
progressively declines to the baseline appear-
ance. Because most sonographic contrast media
are blood pool agents, the sinusoidal phase of
enhancement is different from the interstitial
equilibrium phase of CT imaging.1,9 Probably,
the term portal-sinusoidal phase more appro-
priately describes the enhancement modality of
the liver on contrast-enhanced sonography. As a
matter of fact, there is a clear difference between
arterial and portal phases, whereas there is a
kind of continuity between portal and sinu-
soidal phases, which merge together. The sinu-
soidal phase is also referred to as the late
vascular phase9 or extended portal venous
phase.44
sonoscintigraphy—Synonymous with stimulat-
ed acoustic emission.34 Not related to scintigra-
phy in nuclear medicine. To be avoided.
spleen-specific phase of enhancement—See
parenchymal phase of enhancement.
spoke wheel-shaped pattern10,11—See centrifu-
gal blood supply.
starlike pattern—See centrifugal blood supply.
stellate pattern11,37—See centrifugal blood
supply.
stimulated acoustic emission (acoustically)—
An intermittent pseudo-Doppler technique
based on high-frequency harmonic echoes aris-
ing from microbubble disruption due to high-
intensity pulses. Mosaiclike, intense, but very
transient echoes are color coded using color
Doppler velocity.4,16,34 Also known as color stimu-
lated acoustic emission or transient scattering.16,36
stippled pattern of enhancement—Diffuse,
chaotically disposed discrete vessels within a
lesion. This is a typical color Doppler and con-
trast-enhanced sonographic pattern seen in
HCC.12
subharmonic contrast-enhanced sonography—
An experimental technique using that portion of
the returned signal having a frequency half that
of the transmission frequency. See harmonic
imaging.
supplying artery—A hypertrophied artery that
feeds a mass. It enhances before the mass itself
and is seen as an enhanced vessel outside the
nodule (malignant lesions) or even central to the
nodule (focal nodular hyperplasia).
targeted (or target-specific or therapeutic)
microbubble—A microbubble prepared to
vehiculate ligands specific for a tumor, throm-
bus, or other target. Used in therapeutic ultra-
sound.34
time-intensity (washin-washout) curve30,34—
Graphic plotting of the intensity of a microbub-
ble signal over time from contrast medium
injection.
time to peak—The time intervening between
contrast medium injection and the moment of
maximum contrast enhancement.30
time variance imaging—A technique derived
from power Doppler sonography in which puls-
es are broadband and with high levels of acoustic
power.46 The changes in microbubble shape and
size are reflected in the amplitude and spectral
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energy distribution of the echoes, so that short
sequences of 6 to 10 pulses per line can reveal the
presence of microbubbles. The changes are then
detected as characteristic features of microbub-
bles using a dedicated algorithm.32
tissue (or tissue-specific) contrast medium—
A sonographic contrast medium capable of
being retained within parenchyma (mainly, liver
and spleen). As a matter of fact, some contrast
media are blood pool media, whereas others also
show a delayed parenchymal (postvascular)
phase, similar to superparamagnetic iron oxide
agents used in MRI. Technologies such as stimu-
lated acoustic emission and pulse inversion are
necessary for imaging.34
tissue harmonic imaging25—Harmonic signals
from tissues. See harmonic imaging.
tissue signature imaging—A high-MI, wideband
technique performed with an advanced dynam-
ic flow modality. 
transient hepatic echogenicity difference—
Similar to the transient hepatic attenuation dif-
ference encountered in dynamic CT imaging.
Indicates a nontumoral area, hyperechoic on
arterial phase scans and mainly isoechoic on
venous and delayed phase scans. It reflects per-
fusion changes such as those developing in cases
of perifocal hyperemia, arterioportal fistulas, and
portal venous thrombosis.47
transient scattering—See stimulated acoustic
emission.
transpulmonary contrast medium—All mod-
ern, commercially available contrast media con-
sist of microbubbles able to pass through the
pulmonary vascular bed and reach the left car-
diac chambers and the peripheral circulation. It is
no longer necessary to specify this characteristic. 
tumor stain—Dense (homogeneous or inhomo-
geneous) enhancement of a (hypervascular)
lesion during the arterial phase. An angiographic
term that should be avoided in contrast-
enhanced sonography.
vascular phases of enhancement—Used to indi-
cate the phases when contrast medium
microbubbles circulate within the vascular sys-
tem of the body. They are useful because some
contrast media also show a postvascular phase.
vascular recognition imaging—A real-time, con-
trast-enhanced, single-pulse technique using the
Doppler effect and color coding the flow direc-
tion of contrast-enhanced blood. Signals from
static and moving microbubbles are discriminat-
ed into different colors and superimposed on the
B-mode image.
venous phase of enhancement—The phase of
contrast medium circulation when contrast-
enhanced blood leaves an organ through its
venous drainage. For liver imaging, it is synony-
mous with the sinusoidal phase rather than with
the portal phase.
washin—Enhancement of a vascularized lesion,
vessel lumen, or cardiac chamber. A lesion (or
vessel or chamber) becomes rapidly or slowly
enhanced.
washout—De-enhancement of a vascularized
lesion, vessel lumen, or cardiac chamber. A for-
merly enhanced lesion (or vessel or chamber)
becomes rapidly or slowly less enhanced than
previously. The time of washout indicates when
(if) a lesion turns hypoenhanced, which is a
feature of malignancy. Oppositely, sustained
enhancement is commonly encountered in
benign lesions.
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